Immunovant, Inc.

NasdaqGS:IMVT Rapporto sulle azioni

Cap. di mercato: US$4.3b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Immunovant Proprietà

Chi sono i principali azionisti e gli insider hanno acquistato o venduto?

Recenti transazioni insider

NasdaqGS:IMVT Recenti transazioni di insider da parte di aziende o persone fisiche
DataValoreNomeEntitàRuoloAzioniPrezzo massimo
21 Aug 24SellUS$480,052Peter SalzmannIndividual15,068US$32.32
21 Aug 24SellUS$120,045Eva BarnettIndividual3,768US$32.32
21 Aug 24SellUS$96,437Julia ButchkoIndividual3,027US$32.32
21 Aug 24SellUS$96,437William MaciasIndividual3,027US$32.32
21 Aug 24SellUS$104,976Mark LevineIndividual3,295US$32.32
24 Jul 24SellUS$111,456Mark LevineIndividual4,015US$27.76
24 Jul 24SellUS$95,939Michael GeffnerIndividual3,456US$27.76
24 Jul 24SellUS$78,089Jay StoutIndividual2,813US$27.76
17 Jul 24SellUS$257,888Peter SalzmannIndividual8,685US$30.55
17 Jul 24SellUS$85,132Julia ButchkoIndividual2,867US$30.55
17 Jul 24SellUS$92,733Eva BarnettIndividual3,123US$30.55
17 Jul 24SellUS$90,386William MaciasIndividual3,044US$30.55
17 Jul 24SellUS$74,382Mark LevineIndividual2,505US$30.55
09 Jul 24SellUS$129,609Peter SalzmannIndividual4,619US$28.06
09 Jul 24SellUS$42,848Julia ButchkoIndividual1,527US$28.06
09 Jul 24SellUS$133,201Eva BarnettIndividual4,747US$28.06
22 May 24SellUS$96,125Mark LevineIndividual3,242US$29.65
22 May 24SellUS$96,274William MaciasIndividual3,247US$29.65
22 May 24SellUS$96,274Julia ButchkoIndividual3,247US$29.65
22 May 24SellUS$479,233Peter SalzmannIndividual16,163US$29.65
22 May 24SellUS$119,845Eva BarnettIndividual4,042US$29.65
24 Apr 24SellUS$114,531Mark LevineIndividual3,963US$28.90
24 Apr 24SellUS$94,243Michael GeffnerIndividual3,261US$28.90
24 Apr 24SellUS$209,207Jay StoutIndividual7,239US$28.90
17 Apr 24SellUS$990,269Peter SalzmannIndividual34,079US$29.94
17 Apr 24SellUS$293,923Julia ButchkoIndividual10,115US$29.94
17 Apr 24SellUS$285,554Mark LevineIndividual9,827US$29.94
17 Apr 24SellUS$356,049Eva BarnettIndividual12,253US$29.94
17 Apr 24SellUS$240,602William MaciasIndividual8,280US$29.94
09 Apr 24SellUS$149,882Peter SalzmannIndividual4,807US$31.18
09 Apr 24SellUS$115,023Eva BarnettIndividual3,689US$31.18
09 Apr 24SellUS$32,833Julia ButchkoIndividual1,053US$31.18
22 Feb 24SellUS$486,362Peter SalzmannIndividual13,454US$36.15
22 Feb 24SellUS$77,144Mark LevineIndividual2,134US$36.15
22 Feb 24SellUS$77,578Julia ButchkoIndividual2,146US$36.15
22 Feb 24SellUS$80,289William MaciasIndividual2,221US$36.15
22 Feb 24SellUS$105,920Eva BarnettIndividual2,930US$36.15
26 Jan 24SellUS$114,778Mark LevineIndividual3,027US$38.45
26 Jan 24SellUS$383,012Michael GeffnerIndividual10,101US$38.45
18 Jan 24SellUS$17,397William MaciasIndividual424US$41.03
11 Jan 24SellUS$147,023Eva BarnettIndividual3,515US$42.43
05 Jan 24SellUS$147,568Peter SalzmannIndividual3,824US$38.59
05 Jan 24SellUS$50,051Julia ButchkoIndividual1,297US$38.59
01 Dec 23SellUS$490,668Atul PandeIndividual12,350US$40.46
22 Nov 23SellUS$106,598Mark LevineIndividual3,252US$33.52
22 Nov 23SellUS$107,024Julia ButchkoIndividual3,265US$33.52
22 Nov 23SellUS$531,581Peter SalzmannIndividual16,217US$33.52
22 Nov 23SellUS$107,024William MaciasIndividual3,265US$33.52
22 Nov 23SellUS$132,920Eva BarnettIndividual4,055US$33.52
25 Oct 23SellUS$142,349Mark LevineIndividual4,107US$34.66
19 Oct 23SellUS$19,504William MaciasIndividual530US$36.80
10 Oct 23SellUS$168,244Eva BarnettIndividual4,557US$36.92
05 Oct 23SellUS$189,887Peter SalzmannIndividual5,239US$36.39
05 Oct 23SellUS$62,885Julia ButchkoIndividual1,735US$36.39
02 Oct 23BuyUS$58,000,008Roivant Sciences Ltd.Company1,526,316US$38.00

Volume di insider trading

Acquisto da parte di insider: IMVT insider hanno venduto azioni solo negli ultimi 3 mesi.

Ripartizione della proprietà

Qual è l'assetto proprietario di IMVT?
Tipo di proprietarioNumero di azioniPercentuale di proprietà
Singoli insider1.274.9310,817%
Istituzioni75.027.76448,1%
Aziende pubbliche79.805.33151,1%

Diluizione delle azioni: Gli azionisti sono stati diluiti nell'ultimo anno, con un totale di azioni in circolazione in crescita del 12%.

I principali azionisti

I primi 25 azionisti possiedono 92.02% della società
ProprietàNomeAzioniValore attualeVariazione %Portafoglio %
54,5%
Roivant Sciences Ltd.
79.805.331US$2.4b0%Nessun dato
7,16%
FMR LLC
10.483.875US$311.1m36,9%0,02%
4,45%
The Vanguard Group, Inc.
6.509.753US$193.1m0,49%Nessun dato
3,36%
BlackRock, Inc.
4.916.127US$145.9m9,81%Nessun dato
2,32%
Armistice Capital LLC
3.396.909US$100.8m57%2,46%
2,04%
T. Rowe Price Group, Inc.
2.986.869US$88.6m60,4%0,01%
1,97%
Deep Track Capital, LP
2.883.736US$85.6m485%2,24%
1,86%
State Street Global Advisors, Inc.
2.718.956US$80.7m-25,3%Nessun dato
1,59%
Viking Global Investors LP
2.320.902US$68.9m28,3%0,26%
1,31%
Perceptive Advisors LLC
1.923.786US$57.1m-35,1%1,26%
1,3%
Alpine Global Management, LLC
1.907.704US$56.6m1,33%11,49%
1,25%
Woodline Partners LP
1.823.415US$54.1m41,4%0,5%
0,97%
Geode Capital Management, LLC
1.414.002US$42.0m7,38%Nessun dato
0,93%
Paradigm Biocapital Advisors LP
1.362.827US$40.4m70,6%1,42%
0,81%
Rock Springs Capital Management LP
1.185.654US$35.2m3,09%1,01%
0,8%
Pictet Asset Management Limited
1.174.816US$34.9m-7,15%0,02%
0,71%
Franklin Resources, Inc.
1.033.443US$30.7m27,7%0,01%
0,69%
StemPoint Capital LP
1.011.879US$30.0m61,3%8,22%
0,67%
Capital Research and Management Company
976.237US$29.0m0%Nessun dato
0,62%
Avidity Partners Management, L.P.
908.000US$26.9m79,8%1,04%
0,59%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
864.969US$25.7m-13,8%0,01%
0,56%
Tavistock Life Sciences
825.000US$24.5m0%1,17%
0,53%
Morgan Stanley, Investment Banking and Brokerage Investments
777.461US$23.1m-9,18%Nessun dato
0,51%
Commodore Capital LP
750.990US$22.3m0%1,36%
0,49%
Redmile Group, LLC
720.177US$21.4m-25,7%0,96%